EP3551626
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
:
EP einkaleyfi: Þýðing ekki lögð inn:
19.5.2017:
25.10.2023:
17728326.4
:
18.5.2037
:
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
19.5.2017
25.10.2023
:
Xenon Pharmaceuticals Inc.:
200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, CA
:
ANDREZ, Jean-Christophe:
Burnaby, British Columbia V5G 4W8, CA
:
BOGUCKI, David Earl:
Burnaby, British Columbia V5G 4W8, CA
:
BURFORD, Kristen, Nicole:
Burnaby, British Columbia V5G 4W8, CA
:
CHOWDHURY, Sultan:
Burnaby, British Columbia V5G 4W8, CA
:
COHEN, Charles, Jay:
Burnaby, British Columbia V5G 4W8, CA
:
DECKER, Shannon, Marie:
Burnaby, British Columbia V5G 4W8, CA
:
DEHNHARDT, Christoph, Martin:
Burnaby, British Columbia V5G 4W8, CA
:
DEVITA, Robert, Joseph:
Burnaby, British Columbia V5G 4W8, CA
:
EMPFIELD, James, Roy:
Burnaby, British Columbia V5G 4W8, CA
:
FOCKEN, Thilo:
Burnaby, British Columbia V5G 4W8, CA
:
GRIMWOOD, Michael, Edward:
Burnaby, British Columbia V5G 4W8, CA
:
HASAN, Syed, Abid:
Burnaby, British Columbia V5G 4W8, CA
:
JIA, Qi:
Burnaby, British Columbia V5G 4W8, CA
:
JOHNSON, James, Philip, Jr.:
Burnaby, British Columbia V5G 4W8, CA
:
WILSON, Michael, Scott:
Burnaby, British Columbia V5G 4W8, CA
:
ZENOVA, Alla, Yurevna:
Burnaby, British Columbia V5G 4W8, CA
:
201662432169 P:
9.12.2016:
US
:
US2017033666:
19.5.2017
:
C07D 403/12, C07D 213/76, C07D 237/20, C07D 239/69, C07D 413/12, C07D 261/16, C07D 493/10, C07D 277/52, C07D 285/08, A61K 31/426, A61P 25/08, C07D 417/12